Revival: Delivery Strategies for Antisense Oligonucleotide Therapeutics (1995)

Saghir Akhtar is professor in the Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University.

1. Preface 2. Overview of antisense oligonucleotide therapeutics and delivery 3. Disrupting the flow of genetic information with antisense oligodeoxynucleotides: research and therapeutic applications 4. Cellular delivery of ribozymes 5. Improved structural design and cellular 6. Uptake of gt-rich triplex-forming oligonucleotides 7. Pharmacokinetic and distribution studies 8. Pharmacokinetics and delivery of oligonucleotides to the brain 9. In vivo pharmacokinetics of oligonucleotides following administration by different routes 10. Improving biological stability of oligonucleotides 11. Nuclease-resistant nucleic acid therapeutics 12. Self-stabilized oligonucleotides as novel antisense agents 13. Circular oligonucleotides as potential modulators of gene expression 14. Peptide nucleic acids as antisense therapeutic agents 15. Stabilized rna analogues for antisense and ribozyme applications 16. Improving membrane transport and targeted delivery of antisense oligonucleotides 17. Uptake and localization of phosphodeister and chimeric 18. Oligodeoxynucleotides in normal and leukaemic primary cells 19. Oligonucleotide transport across membranes and into cells: effects of chemical modifications 20. Liposomes as a delivery system for antisense and ribozyme compounds 21. Intracellular delivery of oligonucleotides with cationic liposomes 22. The delivery of oligonucleotides using ph-sensitive liposomes 23. Enhancing endsosomal exit of nucleic acids using ph-sensitive viral fusion peptides 24. Targeted delivery of anti-hepatitis b antisense oligonucleotides 25. Design, synthesis, and cellular delivery of antibody antisense oligonucleotide conjugates for cancer therapy